Quantum-Si: High-Risk, High-Reward Bet on Disrupting Proteomics with Next-Generation Protein Sequencing
Overview
Quantum-Si Incorporated (QSI) is a life sciences innovator seeking to democratize proteomics using its single-molecule Next-Generation Protein Sequencing platform. The company offers a complete ecosystem—benchtop instruments, automated preparation (Carbon), proprietary consumables, and cloud-based analytics—targeting academic, government, and pharmaceutical research labs. The platform allows direct, real-time analysis of proteins, with strong implications for drug discovery, diagnostics, and biomarker development. While the core technology is groundbreaking and the target market vast, QSI is still early in commercialization, striving to build an installed base that will drive high-margin, recurring consumable sales critical for future profitability.